BAT Bets Big on Smokeless: U.S. Momentum Hints at a Market Rebound

British American Tobacco is entering a phase that could redefine its growth outlook after years of stagnation. The company is regaining investor attention as improving U.S. performance and rapid expansion of new-category nicotine products begin to reshape the narrative. Insights shared at the recent Jefferies conference showed a management team that finally speaks with confidence — convinced that its shift from cigarettes to modern alternatives is accelerating faster and more profitably than expected.

At the center of this renewed optimism is the U.S. market for oral nicotine pouches, where BAT’s Velo brand is gaining traction at an impressive pace. While America has historically lagged behind Europe in adoption and innovation, that gap now represents a powerful catalyst. The runway for growth is vast, and early data suggests consumers are switching categories far faster than anticipated. If U.S. usage converges toward European levels, BAT could be looking at the strongest expansion…